PDLIM5 and schizophrenia: Our results support previous findings that showed a significant decrease in PDLIM5 mRNA expression in the lymphoblastoid cell lines of BPD and schizophrenia patients [14,15], as well as in the PBLs of patients with major depressive disorder [13], compared with that in control subjects.